Viktor Grünwald, Lutz Jacobasch, Maike de Wit, Severine Banek, Guenter Niegisch, Mark-Oliver Zahn, Andreas Neisius, Phillip Marks, Mirko Müller, Ludwig von Weikersthal, Andreas Huebner, Marinela Augustin, Eyck von der Heyde, Christian Thomas, Nils Gilbert, Alexander Fehr, Heribert Stauder, Ursula Vehling-Kaiser, Ralf Eckert, Philipp Ivanyi. "A phase III study testing the role of proactive coaching on patient reported outcome in advanced or metastatic renal cell carcinoma treated with sunitinib or a combination of axitinib + pembrolizumab or avelumab in first line therapy (PREPARE; AIO-NZK-0115/ass).." Journal of Clinical Oncology (2025). https://doi.org/10.1200/jco.2025.43.5_suppl.523